Krebs Biochemicals & Industries Limited share price
NSE: KREBSBIO · ISIN INE268B01013
Key numbers
- Market cap
- ₹ 123 Cr
- Current price
- ₹ 56.94
- 52-week high / low
- ₹ 77 / 38
- Stock P/E
- -
- Book value
- ₹ -75.8
- Dividend yield
- 0.00%
- ROCE
- -11.4%
- ROE
- 11.0%
- Debt to equity
- -1.66
- Sales growth (3 yrs)
- -23.1%
- Profit growth (3 yrs)
- -
- 1-year return
- -28.8%
About Krebs Biochemicals & Industries Limited
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 5 | 4 | 7 | 7 | 7 |
| Operating profit | -2 | -3 | 0 | -1 | 1 |
| Net profit | -5 | -6 | -3 | -2 | -2 |
| EPS (₹) | -2.47 | -2.85 | -1.45 | -1.09 | -1.15 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.